Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Invested Capital: 2013-2024

Historic Invested Capital for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $6.6 billion.

  • Surgery Partners' Invested Capital rose 111.55% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 111.55%. This contributed to the annual value of $6.6 billion for FY2024, which is 1306.37% up from last year.
  • According to the latest figures from FY2024, Surgery Partners' Invested Capital is $6.6 billion, which was up 1306.37% from $5.8 billion recorded in FY2023.
  • Surgery Partners' Invested Capital's 5-year high stood at $6.6 billion during FY2024, with a 5-year trough of $2.4 billion in FY2020.
  • Over the past 5 years, Surgery Partners' median Invested Capital value was $5.6 billion (recorded in 2022), while the average stood at $5.1 billion.
  • In the last 5 years, Surgery Partners' Invested Capital increased by 16.55% in 2020 and then soared by 10350.61% in 2021.
  • Annual analysis of 5 years shows Surgery Partners' Invested Capital stood at $2.4 billion in 2020, then surged by 103.51% to $4.9 billion in 2021, then rose by 13.13% to $5.6 billion in 2022, then increased by 4.72% to $5.8 billion in 2023, then increased by 13.06% to $6.6 billion in 2024.
  • Its last three reported values are $6.6 billion in FY2024, $5.8 billion for FY2023, and $5.6 billion during FY2022.